Editorial standards

The site is useful only if the proof stays clean.

Primary sources first

Clinical and regulatory claims are traced back to company releases, regulators, trial registrations, or peer-reviewed sources where available.

No medical advice

This site does not tell readers what to take, how to dose, or whether retatrutide is right for them. Clinical decisions belong with qualified practitioners.

Trademark boundary

We reference Lilly, Mounjaro, Ozempic, and other names to identify the subject matter. We do not claim affiliation, endorsement, authorisation, or official status.

Supplier checks are evidence checks

When we link to a supplier, the frame is proof: batch records, COA, HPLC purity, payment protection, dispatch, and support. It is not a therapeutic recommendation.

Corrections

If a date, status, source, or number changes, email hello@lillyretatrutide.com and we will correct the page with a visible update date.